Henning Beck‐Nielsen

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Philip Home, Stuart Pocock, Henning Beck‐Nielsen et al. · The Lancet · 2009 · 1.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

Philip Home, Stuart Pocock, Henning Beck‐Nielsen et al. · New England Journal of Medicine · 2007 · 763 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - a population-based twin study

Pernille Poulsen, Kirsten Ohm Kyvik, Allan Vaag et al. · Diabetologia · 1999 · 618 citations · Full text

Life Sciences, Endocrinology, Genetics +9

Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes

Martin Mogensen, Kent Sahlin, Maria Fernström et al. · Diabetes · 2007 · 583 citations · Full text

Life Sciences, Biochemistry, Physiology +15

Outcomes in Type 1 Diabetic Pregnancies

Peter Damm, Lars Moelsted-Pedersen, Per Ovesen et al. · Diabetes Care · 2004 · 487 citations · Full text

Public Health, Maternal Health, Obstetrics +17